Karen Baswell is an associate with Chaffetz Lindsey LLP and has experience representing individual and corporate clients in general commercial litigation, as well as regulatory matters, including SEC and U.S. Department of Justice investigations.

Prior matters include a class action involving a leading monoline insurer; representing a leading international financial services company in a dispute over compliance with an arbitration award; representing an international insurance company in several contract disputes with various reinsurers; advising an international reinsurer in a dispute with its retrocessionaire; and securing the dismissal of an adversary proceeding arising out of a major law firm bankruptcy proceeding in the U.S. Bankruptcy Court for the Southern District of New York. Ms. Baswell has also provided advice regarding the enforcement of interim awards in aid of arbitration.

Prior to joining Chaffetz Lindsey LLP, Ms. Baswell was an associate at Clifford Chance. Karen is admitted to practice in New York and New Jersey. She received her JD summa cum laude from Hofstra University, where she was an Articles Editor for the Hofstra Law Review. Karen’s publications include: Time for a Change: Why the FDA Should Require Greater Disclosure of Differences of Opinion on the Safety and Efficacy of Approved Drugs, 35 Hofstra Law Rev. 1799 (2007). She holds a BS and BA from University of Richmond, cum laude.